{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:58:52Z","timestamp":1777931932150,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":2761,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1093\/annonc\/mdr463","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T04:45:35Z","timestamp":1320468335000},"page":"1111-1120","source":"Crossref","is-referenced-by-count":85,"title":["Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts"],"prefix":"10.1016","volume":"23","author":[{"given":"M.","family":"Reck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Barlesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Crin\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.I.","family":"Henschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Isla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Stiebeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"Spigel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr463_bb0010","series-title":"AVASTIN\u00ae (Bevacizumab). Summary of Product Characteristics","author":"Hoffmann-La Roche Ltd","year":"2010"},{"key":"10.1093\/annonc\/mdr463_bb0015","series-title":"AVASTIN\u00ae (Bevacizumab). Solution for Intravenous Infusion, US label","author":"Genentech, Inc","year":"2010"},{"key":"10.1093\/annonc\/mdr463_bb0020","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl 8","key":"10.1093\/annonc\/mdr463_bb0025","first-page":"viii147","article-title":"Meta-analysis of randomized phase II\/III trials adding bevacizumab to platin-based chemotherapy as first-line treatment in patients with advanced non-small cell lung cancer","volume":"21","author":"Soria","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1200\/JCO.2007.14.5466","article-title":"Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAiL","volume":"27","author":"Reck","year":"2009","journal-title":"J Clin Oncol"},{"issue":"Suppl 9","key":"10.1093\/annonc\/mdr463_bb0035","first-page":"ix11","article-title":"Randomized phase II study of bevacizumab combined with CBDCA-PTX in Japanese patients with advanced non-sq NSCLC","volume":"21","author":"Murakami","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0040","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/annonc\/mdq020","article-title":"Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)","volume":"21","author":"Reck","year":"2010","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdr463_bb0045","doi-asserted-by":"crossref","first-page":"v116","DOI":"10.1093\/annonc\/mdq189","article-title":"Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"D'Addario","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0050","unstructured":"National Cancer Institute. Stage IV Non-Small Cell Lung Cancer. http:\/\/www.cancer.gov\/cancertopics\/pdq\/treatment\/non-small-cell-lung\/healthprofessional\/page11. 2011 (16 February 2011, date last accessed)."},{"key":"10.1093\/annonc\/mdr463_bb0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1513\/pats.200807-066LC","article-title":"Angiogenesis in the treatment of non-small cell lung cancer","volume":"6","author":"Horn","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1093\/annonc\/mdr463_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-8722-2-45","article-title":"Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy","volume":"2","author":"Yuan","year":"2009","journal-title":"J Hematol Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1470-2045(10)70151-0","article-title":"Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study","volume":"11","author":"Crin\u00f2","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0070","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.7618","article-title":"Clinical outcomes (CO) for special populations of patients (pts) with advanced non-small cell lung cancer (NSCLC): results from ARIES, a bevacizumab (BV) observational cohort study (OCS)","volume":"28","author":"Wozniak","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0075","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.7619","article-title":"Baseline (BL) radiographic characteristics and severe pulmonary hemorrhage (SPH) in bevacizumab (BV)-treated non-small cell lung cancer (NSCLC) patients (pt): results from ARIES, an observational cohort study (OCS)","volume":"28","author":"Kumar","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000314980","article-title":"Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis","volume":"79","author":"Hapani","year":"2010","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdr463_bb0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.2011.51","article-title":"Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis","volume":"305","author":"Ranpura","year":"2011","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdr463_bb0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1097-0142(19800701)46:1<200::AID-CNCR2820460133>3.0.CO;2-V","article-title":"Hemorrhage from carcinoma of the lung","volume":"46","author":"Miller","year":"1980","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr463_bb0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00000441-198711000-00003","article-title":"Major and massive hemoptysis: reassessment of conservative management","volume":"294","author":"Corey","year":"1987","journal-title":"Am J Med Sci"},{"key":"10.1093\/annonc\/mdr463_bb0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1378\/chest.112.2.440","article-title":"Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital","volume":"112","author":"Hirshberg","year":"1997","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdr463_bb0105","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/archinte.1991.00400120087015","article-title":"A reappraisal of the causes of hemoptysis","volume":"151","author":"Santiago","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1093\/annonc\/mdr463_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1752-699X.2009.00158.x","article-title":"A prospective evaluation of hemoptysis cases in a tertiary referral hospital","volume":"4","author":"Uzun","year":"2010","journal-title":"Clin Respir J"},{"key":"10.1093\/annonc\/mdr463_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1378\/chest.65.3.299","article-title":"Clinical manifestations of lung cancer","volume":"65","author":"Hyde","year":"1974","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdr463_bb0120","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/1097-0142(19851015)56:8<2107::AID-CNCR2820560837>3.0.CO;2-T","article-title":"Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont","volume":"56","author":"Chute","year":"1985","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr463_bb0125","series-title":"The Bronchial Circulation","first-page":"667","article-title":"Endovascular management of bronchial bleeding","author":"Remy","year":"1992"},{"key":"10.1093\/annonc\/mdr463_bb0130","doi-asserted-by":"crossref","first-page":"368S","DOI":"10.1378\/chest.07-1391","article-title":"Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)","volume":"132","author":"Kvale","year":"2007","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdr463_bb0135","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1200\/JCO.2004.11.022","article-title":"Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer","volume":"22","author":"Johnson","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0140","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ctrv.2010.01.003","article-title":"Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma","volume":"36","author":"Schmidinger","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdr463_bb0145","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdr463_bb0150","first-page":"1253","article-title":"Hemoptysis: diagnosis and management","volume":"72","author":"Bidwell","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.1093\/annonc\/mdr463_bb0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00270-009-9788-z","article-title":"Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization","volume":"33","author":"Chun","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1093\/annonc\/mdr463_bb0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000253882","article-title":"Use of multidetector row CT to evaluate the need for bronchial arterial embolization in hemoptysis patients","volume":"80","author":"Mori","year":"2010","journal-title":"Respiration"},{"key":"10.1093\/annonc\/mdr463_bb0165","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1148\/radiology.190.3.8115637","article-title":"Mediastinal invasion by bronchogenic carcinoma: CT signs","volume":"190","author":"Herman","year":"1994","journal-title":"Radiology"},{"key":"10.1093\/annonc\/mdr463_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1148\/radiology.173.1.2781028","article-title":"Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation","volume":"173","author":"Glazer","year":"1989","journal-title":"Radiology"},{"key":"10.1093\/annonc\/mdr463_bb0175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-5223(19)34797-X","article-title":"Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma. A prospective study","volume":"104","author":"Izbicki","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/annonc\/mdr463_bb0180","doi-asserted-by":"crossref","first-page":"40s","DOI":"10.1183\/09031936.02.00270802","article-title":"Computed tomography in staging for lung cancer","volume":"35","author":"Verschakelen","year":"2002","journal-title":"Eur Respir J Suppl"},{"key":"10.1093\/annonc\/mdr463_bb0185","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1148\/radiol.2373040966","article-title":"Imaging of the patient with non-small cell lung cancer","volume":"237","author":"Munden","year":"2005","journal-title":"Radiology"},{"key":"10.1093\/annonc\/mdr463_bb0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s002619900046","article-title":"Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT","volume":"21","author":"Loyer","year":"1996","journal-title":"Abdom Imaging"},{"key":"10.1093\/annonc\/mdr463_bb0195","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2214\/ajr.168.6.9168704","article-title":"Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT","volume":"168","author":"Lu","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1093\/annonc\/mdr463_bb0200","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/annonc\/mdp590","article-title":"Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors","volume":"21","author":"Barlesi","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0205","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.2008.16.2412","article-title":"Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with carboplatin and paclitaxel plus bevacizumab","volume":"27","author":"Sandler","year":"2009","journal-title":"J Clin Oncol"},{"issue":"Suppl 8","key":"10.1093\/annonc\/mdr463_bb0210","first-page":"viii144","article-title":"Safety of first-line bevacizumab (BV)-based therapy in the sail (MO19390) trial: central tumour location (CTL) and hypertension (HTN) in patients (PTS) with advanced non-small cell lung cancer (NSCLC)","volume":"21","author":"Griesinger","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0215","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1200\/JCO.2008.16.2545","article-title":"Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer","volume":"27","author":"Crabb","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/JTO.0b013e318168c7e9","article-title":"Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer","volume":"3","author":"Marom","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0225","first-page":"S84","article-title":"Risk of severe pulmonary hemorrhage (SPH) associated with development of cavitation while on bevacizumab (BV) therapy in patients (PTS) with non small cell lung cancer (NSCLC): results from ARIES, a BV treatment observational cohort study (OCS)","volume":"5","author":"Spigel","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JTO.0b013e3181f94ad4","article-title":"BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin\/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer","volume":"6","author":"Hainsworth","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","article-title":"Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data","volume":"377","author":"Coleman","year":"2011","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdr463_bb0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1200\/JCO.2007.13.1144","article-title":"Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599","volume":"26","author":"Ramalingam","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0245","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1097\/JTO.0b013e3181f49c22","article-title":"Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL)","volume":"5","author":"Leighl","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0250","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjc.6606074","article-title":"Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study","volume":"104","author":"Leighl","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdr463_bb0255","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1378\/chest.118.5.1431","article-title":"Managing life-threatening hemoptysis: has anything really changed?","volume":"118","author":"Haponik","year":"2000","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdr463_bb0260","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1378\/chest.119.3.781","article-title":"Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction","volume":"119","author":"Morice","year":"2001","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdr463_bb0265","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1378\/chest.127.6.2113","article-title":"Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis","volume":"127","author":"Valipour","year":"2005","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdr463_bb0270","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02735578","article-title":"Bronchial artery embolization for hemoptysis: immediate and long-term results","volume":"15","author":"Hayakawa","year":"1992","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1093\/annonc\/mdr463_bb0275","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1378\/chest.121.3.789","article-title":"Bronchial artery embolization: experience with 54 patients","volume":"121","author":"Swanson","year":"2002","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdr463_bb0280","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jvir.2009.02.016","article-title":"Bronchial artery embolization for the management of hemoptysis in oncology patients: utility and prognostic factors","volume":"20","author":"Wang","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1093\/annonc\/mdr463_bb0285","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1200\/JCO.2007.15.3312","article-title":"Palliative thoracic radiotherapy for lung cancer: a systematic review","volume":"26","author":"Fairchild","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr463_bb0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/157488710791233608","article-title":"Hypofractionated radiotherapy in non small cell lung cancer: a review of the current literature","volume":"5","author":"Beli","year":"2010","journal-title":"Rev Recent Clin Trials"},{"key":"10.1093\/annonc\/mdr463_bb0295","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2010.06.019","article-title":"Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity","volume":"71","author":"Reinfuss","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdr463_bb0300","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.athoracsur.2008.11.010","article-title":"Multidisciplinary management of life-threatening massive hemoptysis: a 10-year experience","volume":"87","author":"Shigemura","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/annonc\/mdr463_bb0305","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.athoracsur.2009.06.011","article-title":"Surgical lung resection for severe hemoptysis","volume":"88","author":"Andrejak","year":"2009","journal-title":"Ann Thorac Surg"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419347064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419347064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/5\/1111\/13705418\/mdr463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:25:55Z","timestamp":1624440355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419347064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0923753419347064"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr463","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}